Evidence map›Paper›PMID 42136941›Full record

ArticleFrontiers in chemistry2026

Eco-friendly synthesis of an antimicrobial polymer (1,4-bis(methacryloyl)piperazine) via maghnite catalysis:

Samira Derkaoui, Farouk Boudou, Ahcene Keziz, Alaeddine Berkane, Huda Alsaeedi, David Cornu, Mikhael Bechelany, Ahmed Barhoum

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Samira DerkaouiDepartment of Chemistry, Faculty of Exact and Applied Sciences, Laboratory of Polymer Chemistry, University ORAN 1 Ahmed Ben Bella, Oran, Algeria.
Farouk BoudouDepartment of Applied Molecular Genetics, Faculty of Natural and Life Sciences, University of Science and Technology of Oran, Oran, Algeria.
Ahcene KezizDepartment of Physics, Physics and Chemistry of Materials Laboratory, University of M'sila, M'sila, Algeria.
Alaeddine BerkaneDepartment of Chemistry, Faculty of Sciences, Laboratory of Chemistry, Synthesis, Properties, and Applications (LCSPA), Dr. Moulay Tahar University of Saida, Saïda, Algeria.
Huda AlsaeediDepartment of Chemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
David CornuInstitut Européen des Membranes, IEM, UMR 5635, Université Montpellier, CNRS, Montpellier, France.
Mikhael BechelanyInstitut Européen des Membranes, IEM, UMR 5635, Université Montpellier, CNRS, Montpellier, France.
Ahmed BarhoumSchool of Chemical and Biopharmaceutical Sciences, Technological University Dublin, Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Poly (1,4-bis(methacryloyl)piperazine) (poly (NBMP)) is a piperazine-based polymer with potential biomedical applications. Green clay catalysts, maghnite-H Aim: To synthesize poly (NBMP) via green catalysis, evaluate its structural properties, and investigate its antimicrobial potential along with drug-likeness and molecular interaction profiles of its monomer. Method: The monomer and polymer were synthesized using varying amounts of maghnite-H Results: Monomer yield increased from 40% to 72% with 0-10 wt% maghnite-H Discussion: The findings demonstrate that NBMP forms stable interactions with bacterial proteins, supporting its broad-spectrum antimicrobial activity. The eco-friendly synthesis, favorable drug-likeness, and structural stability highlight NBMP as a promising candidate for future biomedical applications. Further

Indexed as

antimicrobial activitydrug-likenessmaghnite catalysismolecular dockingmolecular dynamicsNBMPpiperazine polymertoxicity predictions

Identifiers

PMID42136941
PMCPMC13169067

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.